{"id":7392,"date":"2021-12-16T07:57:36","date_gmt":"2021-12-16T12:57:36","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/bivalirudin-cas-128270-60-0-es-un-anticoagulante-para-investigacion-de-laboratorio\/"},"modified":"2021-12-16T07:57:36","modified_gmt":"2021-12-16T12:57:36","slug":"bivalirudin-cas-128270-60-0-es-un-anticoagulante-para-investigacion-de-laboratorio","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/es\/product\/bivalirudin-cas-128270-60-0-es-un-anticoagulante-para-investigacion-de-laboratorio\/","title":{"rendered":"Bivalirudin CAS 128270-60-0 es un anticoagulante para investigaci\u00f3n de laboratorio"},"content":{"rendered":"

Bivalirudin CAS 128270-60-0 es un anticoagulante para investigaci\u00f3n de laboratorio<\/strong><\/h2>\n

Nombre del producto: Bivalirudin
\n Sin\u00f3nimos: Bivalirudin, TFA; BIVALIRUDIN; BIVALIRUDIN TRIFLUOROACETATE; BITTERMELONP.E; Human Bivalirudin; DPHE-PRO-ARG-PRO-GLY-GLY-GLY-GLY-ASN-GLY-ASP- PHE-GLU-GLU-LLE-PRO-GLU-GLU-TYR-LEU; Acetato de bivalirudina; Bivalirudina BG 8967, Hirulog, Hirulog I
\n CAS: 128270-60-0
\n MF: C98H138N24O33
\n MW: 2180.29
\n EINECS: 274-570-6
\n Categor\u00edas de productos: API; prote\u00ednas; P\u00e9ptido
\n Mol Archivo: 128270-60-0.mol <\/p>\n

La bivalirudina es un tipo de anticoagulantes sint\u00e9ticos novedosos. Es el inhibidor directo, espec\u00edfico y reversible de la trombina. Fue desarrollado originalmente por Swiss Basset (Biogen). Luego fue transferido a la United States Medicines Company y aprobado para su comercializaci\u00f3n en los Estados Unidos en 2000. Su ingrediente anticoagulante es una especie de 20 p\u00e9ptidos derivados de la hirudina. La bivalirudina puede unirse espec\u00edficamente con el sitio catal\u00edtico y el sitio de uni\u00f3n del ani\u00f3n, ya sea la trombina que se encuentra en la circulaci\u00f3n sangu\u00ednea o la trombina unida al trombo, inhibiendo as\u00ed directamente la actividad de la trombina. Y su papel se caracteriza por ser corto, reversible. Los primeros estudios cl\u00ednicos muestran que el tratamiento anticoagulante de bivalirudina es bueno. Y la incidencia de episodios hemorr\u00e1gicos es baja. Por tanto, su uso es m\u00e1s seguro que la terapia tradicional con heparina. Se utiliza principalmente para la prevenci\u00f3n de angioplastia tratamiento intervencionista de complicaciones isqu\u00e9micas de angina de pecho inestable antes y despu\u00e9s. <\/p>\n

Bivalirudina CAS 128270-60-0 Propiedades qu\u00edmicas<\/strong>
\n densidad 1,52 \u00b1 0,1 g \/ cm3 (Previsto)
\n temperatura de almacenamiento -20 \u00b0 C
\n forma polvo
\n color blanco a blanquecino
\n InChIKey OIRCOABEOLEUMC-GEJPAHFPSA-N <\/p>\n

Usos de bivalirudina CAS 128270-60-0<\/strong>
\n Anticoagulante; antitromb\u00f3tico. <\/p>\n

La bivalirudina es un f\u00e1rmaco anticoagulante sint\u00e9tico, un an\u00e1logo de 20 p\u00e9ptidos de la hirudina, que fue aprobado para su comercializaci\u00f3n en los Estados Unidos en 2000. La bivalirudina se une espec\u00edficamente al sitio catal\u00edtico de la trombina y al sitio de uni\u00f3n externo ani\u00f3nico , inhibiendo directamente la actividad de la trombina y por tanto inhibiendo las reacciones catalizadas e inducidas por la trombina, y su acci\u00f3n es reversible. La bivalirudina se utiliza principalmente como anticoagulante para la intervenci\u00f3n coronaria percut\u00e1nea (ICP) electiva en adultos.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nombre del producto: Bivalirudina
\n CAS: 128270-60-0
\n MF: C98H138N24O33
\n MW: 2180.29
\n EINECS: 274-570-6
\n Mol Archivo: 128270-60-0.mol<\/p>\n","protected":false},"featured_media":2279,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[414],"product_tag":[2394],"class_list":{"0":"post-7392","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptido-sanguineo-y-vascular","7":"product_tag-bivalirudin-cas-128270-60-0-is-an-anticoagulant-for-lab-research-es","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product\/7392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/comments?post=7392"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media\/2279"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media?parent=7392"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_brand?post=7392"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_cat?post=7392"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_tag?post=7392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}